The latest closing stock price for Galectin Therapeutics as of November 22, 2024 is 2.78.
An investor who bought $1,000 worth of Galectin Therapeutics stock at the IPO in 2002 would have $-768 today, roughly -1 times their original investment - a -6.43% compound annual growth rate over 22 years.
The all-time high Galectin Therapeutics stock closing price was 36.84 on September 11, 2003.
The Galectin Therapeutics 52-week high stock price is 4.27, which is 53.6% above the current share price.
The Galectin Therapeutics 52-week low stock price is 1.55, which is 44.2% below the current share price.
The average Galectin Therapeutics stock price for the last 52 weeks is 2.44.
An investor who bought $1,000 worth of Galectin Therapeutics stock at the IPO in 2002 would have $-768 today, roughly -1 times their original investment - a -6.43% compound annual growth rate over 22 years.
The all-time high Galectin Therapeutics stock closing price was 36.84 on September 11, 2003.
The Galectin Therapeutics 52-week high stock price is 4.27, which is 53.6% above the current share price.
The Galectin Therapeutics 52-week low stock price is 1.55, which is 44.2% below the current share price.
The average Galectin Therapeutics stock price for the last 52 weeks is 2.44.